IMCR
Immunocore Holdings plcTrades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-27 | Ratcliffe Peter John |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. |
Share Option (Right to Buy)
|
27,492 |
| 2026-05-27 | Kaul Siddharth |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. |
Share Option (Right to Buy)
|
27,492 |
| 2026-05-27 | Pao William |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. |
Share Option (Right to Buy)
|
27,492 |
| 2026-05-27 | Bell John Irving |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. |
Share Option (Right to Buy)
|
27,492 |
| 2026-05-27 | Herbst Roy Steven |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. |
Share Option (Right to Buy)
|
27,492 |
| 2026-05-27 | Peterson Kristine |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date. |
Share Option (Right to Buy)
|
27,492 |
| 2026-02-18 | St Leger Tina Amber |
CHIEF HR OFFICER |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.17 to $32.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
1,000 |
| 2026-02-18 | Jallal Bahija |
Director, CHIEF EXECUTIVE OFFICER |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted share units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.17 to $32.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
11,474 |
| 2026-02-18 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock units ("RSUs"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.17 to $32.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
5,965 |
| 2026-02-18 | GOLL JOHN |
SVP, FINANCE & CAO |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. The shares were sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted share units ("RSUs") . The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.18 to $32.72 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
698 |
| 2026-02-17 | GOLL JOHN |
SVP, FINANCE & CAO |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Restricted Share Units
|
7,411 |
| 2026-02-17 | GOLL JOHN |
SVP, FINANCE & CAO |
Award↑
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Employee Share Option (Right to Buy)
|
21,252 |
| 2026-02-17 | Jallal Bahija |
Director, CHIEF EXECUTIVE OFFICER |
Award↑
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Employee Share Option (Right to Buy)
|
395,066 |
| 2026-02-17 | Coy Travis Alan |
Chief Financial Officer |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each restricted share unit ("RSU") represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Restricted Share Units
|
33,353 |
| 2026-02-17 | Jallal Bahija |
Director, CHIEF EXECUTIVE OFFICER |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Ordinary Shares
|
23,817 |
| 2026-02-17 | St Leger Tina Amber |
CHIEF HR OFFICER |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Ordinary Share. On February 17, 2025, the Reporting Person was granted 8,476 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Restricted Share Units
|
2,119 |
| 2026-02-17 | Coy Travis Alan |
Chief Financial Officer |
Award↑
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Employee Share Option (Right to Buy)
|
95,637 |
| 2026-02-17 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Ordinary Shares
|
11,824 |
| 2026-02-17 | Jallal Bahija |
Director, CHIEF EXECUTIVE OFFICER |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Restricted Share Units
|
88,573 |
| 2026-02-17 | GOLL JOHN |
SVP, FINANCE & CAO |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Ordinary Shares
|
1,351 |
| 2026-02-17 | Jallal Bahija |
Director, CHIEF EXECUTIVE OFFICER |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Ordinary Share. On February 17, 2025, the Reporting Person was granted 95,270 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Restricted Share Units
|
23,817 |
| 2026-02-17 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Ordinary Share. On February 17, 2025, the Reporting Person was granted 47,297 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Restricted Share Units
|
11,824 |
| 2026-02-17 | St Leger Tina Amber |
CHIEF HR OFFICER |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Ordinary Shares
|
2,119 |
| 2026-02-17 | GOLL JOHN |
SVP, FINANCE & CAO |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Ordinary Share. On February 17, 2025, the Reporting Person was granted 5,405 RSUs, vesting in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date. Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share. |
Restricted Share Units
|
1,351 |
| 2025-12-05 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
572 |
| 2025-12-05 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
572 |
| 2025-12-05 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
572 |
| 2025-12-04 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
31,341 |
| 2025-12-04 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
31,341 |
| 2025-12-04 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.44 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
31,341 |
| 2025-11-28 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
5,521 |
| 2025-11-28 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
5,521 |
| 2025-11-28 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
5,521 |
| 2025-11-26 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
69,404 |
| 2025-11-26 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
69,404 |
| 2025-11-26 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
69,404 |
| 2025-11-25 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
18,020 |
| 2025-11-25 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
18,020 |
| 2025-11-25 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
18,020 |
| 2025-11-24 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
100 |
| 2025-11-24 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
100 |
| 2025-11-24 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
100 |
| 2025-09-30 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
61,849 |
| 2025-09-30 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
61,849 |
| 2025-09-30 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
61,849 |
| 2025-09-15 | Berman David M |
HEAD OF R&D |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. |
Ordinary Shares
|
200 |
| 2025-09-15 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
200 |
| 2025-09-15 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
200 |
| 2025-09-12 | Berman David M |
HEAD OF R&D |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.22 to $36.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
21,232 |
| 2025-09-12 | Berman David M |
HEAD OF R&D |
Convert↓
Filing footnotes — Employee Share Option (Right to Buy) (Direct)
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025. Immediately exercisable. |
Employee Share Option (Right to Buy)
|
22,532 |